Boston Therapeutics, Inc. (BTHE) and trades at $0.01. The 52-week range is 0.0091-0.0119.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.2, Earnings Per Share (EPS) of $-0.01, annual revenue of $9.34K.
The stock has a beta of -0.78, operates in the Healthcare sector.
